Pacific Biosciences of California Inc. sell StockNews.com
Start price
29.12.23
/
50%
€9.37
Target price
29.12.24
-
Performance (%)
-86.94%
Price
29.08.24
€1.22
Summary
This prediction is currently active. The SELL prediction by StockNews_com for Pacific Biosciences of California Inc. is performing very well with a performance of -86.94%. This prediction currently runs until 29.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacific Biosciences of California Inc. | -5.324% | -5.324% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
Comments by StockNews_com for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for PACB provided by MarketBeat
Stopped prediction by StockNews_com for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.39
18.04.24
18.04.24
-
18.04.25
18.04.25
-11.97%
29.08.24
29.08.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€3.86
12.03.24
12.03.24
-
12.03.25
12.03.25
-68.32%
29.08.24
29.08.24
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€5.85
13.01.24
13.01.24
-
13.01.25
13.01.25
-79.09%
29.08.24
29.08.24